SCHEDULE: Wolverine Group Discloses 9.03% Stake in Translational Development
Beneficial Ownership Disclosure
Wolverine Asset Management and affiliated entities reported a 9.03% beneficial ownership stake in Translational Development Acquisition Corp.'s Class A ordinary shares.
Summary
- Wolverine Asset Management LLC, along with Wolverine Trading Partners, Inc., Wolverine Holdings, L.P., Christopher L. Gust, and Robert R. Bellick, collectively reported beneficial ownership of 1,557,134 Class A ordinary shares of Translational Development Acquisition Corp.
- This ownership represents 9.03% of the issuer's Class A ordinary shares outstanding.
- The percentage was calculated based on 17,250,000 Class A ordinary shares outstanding as of August 14, 2025, as reported in the issuer's Form 10-Q.
- All reporting persons share voting and dispositive power over the 1,557,134 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a standard disclosure of beneficial ownership by an institutional investor and does not contain information that would inherently sway sentiment positively or negatively regarding the issuer's operational performance or future prospects.
Positives
- A significant institutional investor, Wolverine Asset Management and its affiliates, holds a substantial 9.03% stake, which can signal confidence in the company.
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
This filing indicates a significant passive investment by a financial institution in a SPAC (Special Purpose Acquisition Company) or a company that was a SPAC. Such investments are common for institutional funds seeking exposure or arbitrage opportunities.
Related Party Transactions
- Wolverine Flagship Fund Trading Limited is known to have the right to receive dividends or proceeds from the sale of the Class A ordinary shares beneficially owned by Wolverine Asset Management LLC, indicating it is the ultimate economic beneficiary.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake (9.03%) by Wolverine Asset Management and its affiliates may be viewed positively, potentially increasing investor confidence and liquidity.
Key Dates
| Date | Description |
|---|---|
| 2025-08-14 | Date of Issuer's Form 10-Q, which reported 17,250,000 Class A ordinary shares outstanding. |
| 2025-09-30 | Date of event requiring the filing of this statement. |
| 2025-10-07 | Date of signing for the Schedule 13G filing. |
Keywords
Translational Development Acquisition Corp., Wolverine Asset Management, Schedule 13G, beneficial ownership, Class A ordinary shares, institutional investor, equity stake, G9008W105
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.